Shares and Stockholders' Equity (Tables)

3 Months Ended

Mar. 31, 2023

Shares and Stockholders' Equity [Abstract]

Changes In Common stock (Number Of Shares)

	As of March 31, 2023			As of December 31, 2022
	Shares Authorized	Shares Issued	Shares Outstanding	Shares Authorized	Shares Issued	Shares Outstanding
9.250% Fixed Rate Reset Non-Cumulative
Preferred Stock, Series C	20,000	20,000	20,000	20,000	20,000	20,000
9.000% Non-Cumulative Preferred Stock, Series D	20,000	20,000	20,000	20,000	20,000	20,000
Not designated	9,960,000	-	-	9,960,000	-	-
Total preferred shares	10,000,000	40,000	40,000	10,000,000	40,000	40,000

Schedule of Stock by Class

	For the Three Months Ended March 31,
	2023		2022
	Dividend	Aggregate	Dividend	Aggregate
Series	Per Share	Dividend	Per Share	Dividend
Series C	$      635.94	$             13	$               -	$               -
Series D	618.75	12	-	-
Total	$   1,254.69	$             25	$               -	$               -

Schedule of Common Stock Outstanding Roll Forward

	For the Three
	Months Ended
	March 31,
	2023	2022
Common Stock
Balance as of beginning-of-year	169,220,511	177,193,515
Stock compensation/issued for benefit plans	317,248	514,855
Retirement/cancellation of shares	-	(5,817,396	)
Balance as of end-of-period	169,537,759	171,890,974
Common Stock as of End-of-Period
Basic basis	169,537,759	171,890,974
Diluted basis	170,474,027	173,761,296

Reconciliation Of The Denominator Calculations Of Basic And Diluted EPS

	For the Three
	Months Ended
	March 31,
	2023		2022
Weighted-average shares, as used in basic calculation	169,357,846		174,153,475
Shares to cover non-vested stock	568,126		1,359,873
Average stock options outstanding during the period	26,423		2,296,869
Assumed acquisition of shares with assumed
proceeds and benefits from exercising stock
options (at average market price for the period)	(21,201	)	(1,825,626	)
Shares repurchasable from measured but
unrecognized stock option expense	-		(71,253	)
Average deferred compensation shares	553,966		521,211
Weighted-average shares, as used in diluted calculation (1)	170,485,160		176,434,549

⁽¹⁾Due to reporting a net loss for the three months ended March 31, 2023, basic shares were used in the diluted earnings per share calculation for this period as the use of diluted shares would have resulted in a lower loss per share.

Components And Changes In Accumulated OCI

	For the Three
	Months Ended
	March 31,
	2023			2022
Unrealized Gain (Loss) on Fixed Maturity AFS Securities and Certain Other
Investments
Balance as of beginning-of-year	$	(8,916	)	$	9,616
Unrealized holding gains (losses) arising during the period		2,357			(10,493	)
Change in foreign currency exchange rate adjustment		76			(71	)
Change in future contract benefits and other policyholder account balances		(260	)		921
Income tax benefit (expense)		(465	)		2,057
Less:
Reclassification adjustment for gains (losses) included in net income (loss)		(39	)		(2	)
Income tax benefit (expense)		8			-
Balance as of end-of-period	$	(7,177	)	$	2,032
Unrealized Gain (Loss) on Derivative Instruments
Balance as of beginning-of-year	$	388		$	(85	)
Unrealized holding gains (losses) arising during the period		134			44
Change in foreign currency exchange rate adjustment		(67	)		75
Income tax benefit (expense)		(15	)		(24	)
Less:
Reclassification adjustment for gains (losses) included in net income (loss)		22			11
Income tax benefit (expense)		(5	)		(2	)
Balance as of end-of-period	$	423		$	1
Market Risk Benefit Non-Performance Risk Gain (Loss)
Balance as of beginning-of-year	$	1,741		$	1,951
Adjustment arising during the period		1,306			25
Income tax benefit (expense)		(281	)		(5	)
Balance as of end-of-period	$	2,766		$	1,971
Policyholder Liability Discount Rate Remeasurement Gain (Loss)
Balance as of beginning-of-year	$	747		$	(1,265	)
Adjustment arising during the period		(258	)		1,031
Income tax benefit (expense)		56			(220	)
Balance as of end-of-period	$	545		$	(454	)
Foreign Currency Translation Adjustment
Balance as of beginning-of-year	$	(34	)	$	(14	)
Foreign currency translation adjustment arising during the period		3			(5	)
Balance as of end-of-period	$	(31	)	$	(19	)
Funded Status of Employee Benefit Plans
Balance as of beginning-of-year	$	(278	)	$	(219	)
Adjustment arising during the period		(2	)		4
Income tax benefit (expense)		-			(1	)
Balance as of end-of-period	$	(280	)	$	(216	)

Schedule of Reclassifications Out Of AOCI

	For the Three
	Months Ended
	March 31,
	2023			2022
Unrealized Gain (Loss) on Fixed Maturity AFS
Securities and Certain Other Investments
Reclassification	$	(39	)	$	(2	)	Realized gain (loss)
Reclassification before income
tax benefit (expense)		(39	)		(2	)	Income (loss) before taxes
Income tax benefit (expense)		8			-		Federal income tax expense (benefit)
Reclassification, net of income tax	$	(31	)	$	(2	)	Net income (loss)
Unrealized Gain (Loss) on Derivative Instruments
Interest rate contracts	$	-		$	1		Net investment income
Interest rate contracts		6			(6	)	Interest and debt expense
Foreign currency contracts		14			13		Net investment income
Foreign currency contracts		2			3		Realized gain (loss)
Reclassifications before income
tax benefit (expense)		22			11		Income (loss) before taxes
Income tax benefit (expense)		(5	)		(2	)	Federal income tax expense (benefit)
Reclassifications, net of income tax	$	17		$	9		Net income (loss)